中国临床肿瘤学会肺癌诊疗指南(2018版)更新解读

被引：157

作者：

李东航 ^{[1
]}

姚颐 ^{[2
]}

耿庆 ^{[1
]}

机构：

[1] 武汉大学人民医院胸外科

[2] 武汉大学人民医院肿瘤中心

来源：

临床外科杂志 | 2019年 / 27卷 / 01期

关键词：

肺癌; 诊疗; 指南; 解读;

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100117 [系统生物医学];

摘要：

<正>在世界范围内,肺癌是发病率和病死率均排名第一的恶性肿瘤,多数病人确诊时已属晚期,预后常不佳。因此,基于循证医学证据,同时结合我国国情,中国临床肿瘤学会(CSCO)在2016年首次发布了《原发性肺癌诊疗指南》,今年迎来了该指南的第二次更新。2018版《原发性肺癌诊疗指南》(新版《指南》)在2017版的基础上吸收了精准医学的新进展,对肺癌分子分型及基于病理类型、分期和分子分型的综合治疗与时

引用

页码：36 / 39

页数：4

共 11 条

[1]

Icotinib versus whole-brain irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial [J].

Yang, Jin-Ji ;

Zhou, Caicun ;

Huang, Yisheng ;

Feng, Jifeng ;

Lu, Sun ;

Song, Yong ;

Huang, Cheng ;

Wu, Gang ;

Zhang, Li ;

Cheng, Ying ;

Hu, Chengping ;

Chen, Gongyan ;

Zhang, Li ;

Liu, Xiaoqing ;

Yan, Hong Hong ;

Tan, Fen Lai ;

Zhong, Wenzhao ;

Wu, Yi-Long .

LANCET RESPIRATORY MEDICINE, 2017, 5 (09) :707-716

[2]

Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer.[J].Onkar V. Khullar;Yuan Liu;Theresa Gillespie;Kristin A. Higgins;Suresh Ramalingam;Joseph Lipscomb;Felix G Fernandez.Journal of Thoracic Oncology.2015, 11

[3]

Genetic Cancer Susceptibility Testing: Increased Technology, Increased Complexity [J].

Yu, Peter Paul ;

Vose, Julie M. ;

Hayes, Daniel F. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (31) :3533-+

[4]

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility [J].

Robson, Mark E. ;

Bradbury, Angela R. ;

Arun, Banu ;

Domchek, Susan M. ;

Ford, James M. ;

Hampel, Heather L. ;

Lipkin, Stephen M. ;

Syngal, Sapna ;

Wollins, Dana S. ;

Lindor, Noralane M. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (31) :3660-+

[5]

Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non–Small-Cell Lung Cancer: A Systematic Review.[J].Madhusmita Behera;Rathi N. Pillai;Taofeek K. Owonikoko;Sungjin Kim;Conor Steuer;Zhengjia Chen;Nabil F. Saba;Chandra P. Belani;Fadlo R. Khuri;Suresh S. Ramalingam.Journal of Thoracic Oncology.2015, 8

[6]

College of American Pathologists' Laboratory Standards for Next-Generation Sequencing Clinical Tests [J].

Aziz, Nazneen ;

Zhao, Qin ;

Bry, Lynn ;

Driscoll, Denise K. ;

Funke, Birgit ;

Gibson, Jane S. ;

Grody, Wayne W. ;

Hegde, Madhuri R. ;

Hoeltge, Gerald A. ;

Leonard, Debra G. B. ;

Merker, Jason D. ;

Nagarajan, Rakesh ;

Palicki, Linda A. ;

Robetorye, Ryan S. ;

Schrijver, Iris ;

Weck, Karen E. ;

Voelkerding, Karl V. .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (04) :481-493

[7]

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study [J].

Bradley, Jeffrey D. ;

Paulus, Rebecca ;

Komaki, Ritsuko ;

Masters, Gregory ;

Blumenschein, George ;

Schild, Steven ;

Bogart, Jeffrey ;

Hu, Chen ;

Forster, Kenneth ;

Magliocco, Anthony ;

Kavadi, Vivek ;

Garces, Yolanda I. ;

Narayan, Samir ;

Iyengar, Puneeth ;

Robinson, Cliff ;

Wynn, Raymond B. ;

Koprowski, Christopher ;

Meng, Joanne ;

Beitler, Jonathan ;

Gaur, Rakesh ;

Curran, Walter, Jr. ;

Choy, Hak .

LANCET ONCOLOGY, 2015, 16 (02) :187-199

[8]

Crizotinib in ROS1 -Rearranged Non–Small-Cell Lung Cancer.[J].Alice T. Shaw;Sai-Hong I. Ou;Yung-Jue Bang;D. Ross Camidge;Benjamin J. Solomon;Ravi Salgia;Gregory J. Riely;Marileila Varella-Garcia;Geoffrey I. Shapiro;Daniel B. Costa;Robert C. Doebele;Long Phi Le;Zongli Zheng;Weiwei Tan;Patricia Stephenson;S. Martin Shreeve;Lesley M. Tye;James G. Christensen;Keith D. Wilner;Jeffrey W. Clark;A. John Iafrate.The New England Journal of Medicine.2014, 21

[9]

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study.[J].Glenwood D. Goss;Chris O'Callaghan;Ian Lorimer;Ming-Sound Tsao;Gregory A. Masters;James Jett;Martin J. Edelman;Rogerio Lilenbaum;Hak Choy;Fadlo Khuri;Katherine Pisters;David Gandara;Kemp Kernstine;Charles Butts;Jonathan Noble;Thomas A. Hensing;Kendrith Rowland;Joan Schiller;Keyue Ding;Frances A. Shepherd.Journal of Clinical Oncology.2013, 27

[10]

Identification of driver mutations in lung cancer: first step in personalized cancer [J].

Planchard, David .

TARGETED ONCOLOGY, 2013, 8 (01) :3-14

← 1 2 →